Molecular characterization of extended-spectrum β-lactamases-producing Escherichia coli and Klebsiella pneumoniae in hospitals of the Caribean Region, Colombia

被引:0
作者
Gaitan C, Sandra L. [1 ]
Espinal M, Paula A. [1 ]
机构
[1] Univ Sinu, Fac Ciencias Salud, Grp Enfermedades Trop & Resistencia Bacteriana, Monteria, Colombia
来源
REVISTA CHILENA DE INFECTOLOGIA | 2009年 / 26卷 / 03期
关键词
Escherichia coli; Klebsiella pneumoniae; beta-lactamases; ESBL; Colombia; FIELD GEL-ELECTROPHORESIS; PSEUDOMONAS-SPP; EPIDEMIOLOGY; PREVALENCE; RESISTANCE; ENTEROBACTERIACEAE; MUTATIONS;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
ESBL-producing in Enterobacteriaceae, is the main resistance mechanism to extended spectrum cephalosporin and monobactams. Seventy isolates collected of hospitals in four cities of the Colombian Caribean, were characterized to ESBL production and metalo-beta-lactamases by microbiological test. The beta-lactamases characterization were performed by IEF and RPC; genotyping by PFGE. Results evidenced the ESBL production at four cities with more frequency in Klebsiella pneumoniae isolated from UCI. The beta-lactamases present in Escherichia coli and in K. pneumoniae contributed co-resistance to different antibiotic families. Enzymes were detected with resistance to cephalosporin and carbapenems, suggesting presence of carbapenemases. Polyclonal isolates noticed, neither demonstrated presence of endemic strains nor association with epidemic outbreak. It is evident the importance to combine clinical, microbiological and molecular information to surveillance the prevalence and evolution of these enzymes in these hospitals.
引用
收藏
页码:239 / 246
页数:8
相关论文
共 32 条
[1]   Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat [J].
Bradford, PA .
CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) :933-951
[2]   Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria [J].
Cirz, RT ;
Romesberg, FE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :220-225
[3]  
Clinical and Laboratory Standards Institute, 2006, PERF STAND ANT SUS S
[4]   Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals [J].
Edelstein, M ;
Pimkin, M ;
Palagin, I ;
Edelstein, I ;
Stratchounski, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (12) :3724-3732
[5]   Emergence of enterobactefiaceae isolates producing CTX-M extended-spectrum β-lactamase in Austria [J].
Eisner, A ;
Fagan, EJ ;
Feierl, G ;
Kessler, HH ;
Marth, E ;
Livermore, DM ;
Woodford, N .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) :785-787
[6]  
ESPINAL P, 2006, 46 INT C ANT AG CHEM
[7]  
GALES C, 1998, J ANTIMICROB CHEMOTH, V45, P295
[8]   Multidrug resistance in gram-negative bacteria that produce extended-spectrum β-lactamases (ESBLs) [J].
Giamarellou, H .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 :1-16
[9]  
Hemalatha V, 2005, INDIAN J MED RES, V122, P148
[10]  
HERNANDEZ J, 2003, 43 INT C ANT AG CHEM